Aimei Health Technology Stock Working Capital
| AFJK Stock | 10.95 0.00 0.00% |
Aimei Health Technology fundamentals help investors to digest information that contributes to Aimei Health's financial success or failures. It also enables traders to predict the movement of Aimei Stock. The fundamental analysis module provides a way to measure Aimei Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aimei Health stock.
Aimei |
Aimei Health Technology Company Working Capital Analysis
Aimei Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Aimei Health Technology has a Working Capital of 0.0. This is 100.0% lower than that of the Life Sciences Tools & Services sector and about the same as Health Care (which currently averages 0.0) industry. The working capital for all United States stocks is 100.0% higher than that of the company.
Aimei Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimei Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimei Health could also be used in its relative valuation, which is a method of valuing Aimei Health by comparing valuation metrics of similar companies.Aimei Health is currently under evaluation in working capital category among its peers.
Aimei Fundamentals
| Current Valuation | 66.45 M | ||||
| Shares Outstanding | 6.12 M | ||||
| Shares Owned By Insiders | 33.60 % | ||||
| Shares Owned By Institutions | 66.40 % | ||||
| Number Of Shares Shorted | 34 | ||||
| Book Value Per Share | (0.09) X | ||||
| Market Capitalization | 67.03 M |
About Aimei Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aimei Health Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aimei Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aimei Health Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Aimei Health Piotroski F Score and Aimei Health Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aimei Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aimei Health Technology is measured differently than its book value, which is the value of Aimei that is recorded on the company's balance sheet. Investors also form their own opinion of Aimei Health's value that differs from its market value or its book value, called intrinsic value, which is Aimei Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aimei Health's market value can be influenced by many factors that don't directly affect Aimei Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aimei Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aimei Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aimei Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.